title: Plasma TGF beta in systemic sclerosis: a cross-sectional study.
abstract: OBJECTIVE
  To determine whether the active 25 kDa form of the fibrogenic cytokine transforming growth factor beta (TGF beta) can be detected in plasma from patients with systemic sclerosis and to examine the relationship between plasma TGF beta and clinical markers of disease severity and serum concentrations of the aminoterminal peptide of type III procollagen (PIIINP) (a laboratory marker of the fibrotic process).
  
  
  METHODS
  A cross sectional study was made of 39 patients with systemic sclerosis (11 diffuse and 28 limited), nine patients with primary Raynaud's disease and 60 healthy controls. TGF beta 1 and TGF beta 2 were measured by enzyme linked immunosorbent assay (ELISA) (sensitivity 100 pg/ml) and PIIINP by radioimmunoassay.
  
  
  RESULTS
  TGF beta 1 was detected in plasma from six of 39 patients with systemic sclerosis but not in any patient with primary Raynaud's disease or healthy controls. TGF beta 2 was not detected in plasma from patients or controls. No clear relationship was demonstrated between TGF beta 1, clinical features or PIIINP concentrations.
  
  
  CONCLUSIONS
  The 25 kDa form of TGF beta 1 can be detected in the plasma of some patients with systemic sclerosis. This provides limited support for the hypothesis that this cytokine plays a role in the pathogenesis of this disease. However, longitudinal studies, particularly in early diffuse disease, are required to clarify the relationship between circulating TGF beta 1 and disease activity.
authors: Department of Immunology, St Mary's Hospital, Manchester.
authors: N
authors: N
authors: Snowden
authors: B
authors: B
authors: Coupes
authors: A
authors: A
authors: Herrick
authors: K
authors: K
authors: Illingworth
authors: M I
authors: MI
authors: Jayson
authors: P E
authors: PE
authors: Brenchley
mesh_terms: D000328:Adult; D003430:Cross-Sectional Studies; D018450:Disease Progression; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments / Q000097:blood; D011347:Procollagen / Q000097:blood; D011928:Raynaud Disease / Q000097:blood; D012595:Scleroderma, Systemic / Q000097:blood* / Q000473:pathology; D016212:Transforming Growth Factor beta / Q000097:blood*
chemical_list: D010446:Peptide Fragments; D011347:Procollagen; D016212:Transforming Growth Factor beta; C041876:procollagen Type III-N-terminal peptide